1. Home
  2. BLDR vs GKOS Comparison

BLDR vs GKOS Comparison

Compare BLDR & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Builders FirstSource Inc.

BLDR

Builders FirstSource Inc.

HOLD

Current Price

$67.14

Market Cap

8.0B

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$170.51

Market Cap

9.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLDR
GKOS
Founded
1998
1998
Country
United States
United States
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
9.0B
IPO Year
2005
2015

Fundamental Metrics

Financial Performance
Metric
BLDR
GKOS
Price
$67.14
$170.51
Analyst Decision
Buy
Strong Buy
Analyst Count
18
12
Target Price
$121.76
$126.92
AVG Volume (30 Days)
2.1M
747.7K
Earning Date
04-30-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$15,190,638,000.00
$507,442,000.00
Revenue This Year
$0.71
$23.32
Revenue Next Year
$4.52
$27.43
P/E Ratio
N/A
N/A
Revenue Growth
N/A
32.33
52 Week Low
$65.10
$73.16
52 Week High
$151.03
$166.00

Technical Indicators

Market Signals
Indicator
BLDR
GKOS
Relative Strength Index (RSI) 36.61 69.55
Support Level $65.10 $98.22
Resistance Level $79.90 N/A
Average True Range (ATR) 3.41 7.15
MACD -0.54 -0.60
Stochastic Oscillator 2.78 81.04

Price Performance

Historical Comparison
BLDR
GKOS

About BLDR Builders FirstSource Inc.

Builders FirstSource Inc is a manufacturer and supplier of building materials. The company offers structural and related building products such as factory-built roof and floor trusses, wall panels and stairs, vinyl windows, custom millwork and trim, and engineered wood. The products can be designed for each home individually and are installed by Builders FirstSource. The company's construction-related services include professional installation, turn-key framing, and shell construction. Builders FirstSource's customers range from large production builders to small custom homebuilders.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: